Increased Invasiveness and Aggressiveness in Breast Epithelia with Cytop- Lasmic P63 Expression Yi-Hsuan Hsiao1,2, Yan A

Increased Invasiveness and Aggressiveness in Breast Epithelia with Cytop- Lasmic P63 Expression Yi-Hsuan Hsiao1,2, Yan A

Int. J. Biol. Sci. 2010, 6 428 International Journal of Biological Sciences 2010; 6(5):428-442 © Ivyspring International Publisher. All rights reserved Research Paper Increased invasiveness and aggressiveness in breast epithelia with cytop- lasmic p63 expression Yi-Hsuan Hsiao1,2, Yan A. Su3, Horng-Der Tsai2, Jeffrey T. Mason4, Ming-Chih Chou1 , Yan-gao Man4 1. Institute of Medicine, Chung Shan Medical University, Taiwan 2. Department of Obstetrics and Gynecology, Changhua Christian Hospital, Taiwan; 3. Department of Gene and Protein Biomarkers, GenProMarkers, Inc. Rockville, MD, USA; 4. Armed Forces Institute of Pathology and American Registry of Pathology, Washington DC, USA Corresponding author: Yan-gao Man, MD., PhD., Director of Gynecologic and Breast Research Laboratory, Department of Gynecologic and Breast Pathology, Armed Forces Institute of Pathology and American Registry of Pathology. Tel: 202-782-1612; Fax: 202-782-3939; E-mail: [email protected]. Or Ming-Chih Chou, MD., PhD., Professor, Department of Sur- gery, Member, Board of Trustees, Chung Shan Medical University, Taichung, Taiwan. Tel: 886-4-24730022; Fax: 886-4-24723229; E-mail: [email protected] Received: 2010.07.16; Accepted: 2010.08.05; Published: 2010.08.08 Abstract Our previous studies revealed that pregnancy associated breast cancer (PABC) had signifi- cantly reduced nuclear p63 expression in myoepithelia, while intense cytoplasmic p63 ex- pression in associated epithelia. Our current study assessed these epithelia using immuno- histochemistry with a panel of aggressiveness and invasiveness related markers and com- parative genomic hybridization (array-CGH) with over 30,000 DNA probes. These epithelia showed several unique alterations, including (1) immunohistochemical and morphological resemblance to invasive cancer, (2) significant gain in copy numbers of DNA coding genes for morphogenesis, angiogenesis, and metastasis, and (3) significant loss in copy numbers of DNA coding genes for tumor suppressors, cell adhesion, and macromolecular complex assembly or intra-cellular trafficking. Detected array-CGH alterations correlated well with in vivo ex- pression of a number of corresponding proteins tested. These findings suggest that aberrant sub-cellular localization of p63 expression in normal or hyperplastic appearing epithelial cells may significant contribute to increased invasiveness and aggressiveness of these cells. Key words: breast epithelia, pregnancy associated breast cancer, p63 expression, invasiveness and aggressiveness. Introduction Pregnancy-associated breast cancer (PABC), alterations of the microenvironment and extracellular which occurs during pregnancy or within one year of matrix [3,4]. Neither the molecular or cellular me- delivery, is the second most common cancer in preg- chanisms, nor the specific molecules linking to ag- nant women [1-3]. A normal full-term pregnancy is gressiveness and invasiveness of PABC, however, believed to be one of the most effective means to de- have been identified. crease the lifetime-risk of breast cancer, whereas Promoted by the fact that the myoepithelium is PABC is associated with the most aggressive clinical the sole source of several tumor suppressors, includ- course and the highest mortality rate among breast ing maspin, Wilms’ tumor 1 (WT-1), p63, and p73, malignancies [1-3]. These seemingly conflicting im- which show significant paracrine inhibition on tumor pacts are believed to result from aberrant proliferation cell growth and invasion in vitro [5-10], our recent and differentiation of stem cells, and pathological studies compared the expression of these tumor sup- http://www.biolsci.org Int. J. Biol. Sci. 2010, 6 429 pressors in PABC and the stage, grade, and age tumor suppressors, including maspin (clone:EAW24), matched non-PABC. PABC were found to have sev- WT-1 (clone: 6F-H2), p63 (clone: 4A4), p53 eral unique alterations, including (1) the absence of (clone:DO-7), p73 (clone:24) (Novocastra Laboratories p63 and WT-1 expression in a vast majority of myoe- Ltd, Newcastle, UK), and proliferation marker Ki-67 pithelial cells, and (2) intense cytoplasmic p63 ex- (clone:MM1; Dako, Carpinteria, CA). The expression pression in a subset of normal or hyperplastic epi- of these markers in myoepithelial and associated ep- thelial cells, which are arranged as segregated clusters ithelial cells of the same acini at different sections or lobules [11]. were digitally photographed and reviewed under Our findings appear to have significant scientific high magnification in a standard computer. Second, and clinical implications for several reasons. First, as the physical distribution of these acini was examined the p63 gene encodes multiple protein isoforms that to determine whether they were exclusively or prefe- regulate p53, p73, and other tumor suppressors rentially associated or shared a similar morphological [12,13], aberrant p63 expression may result in aberrant or immunohistochemical profile, with invasive le- expression of these tumor suppressors. Second, as p63 sions. is required for normal development of the breast and Immunohistochemistry for all antibodies was other organs [12,13], aberrant p63 expression may carried out using protocols provided by manufactur- result in structural defects of breast tissues, making ers. Double immunohistochemistry was carried out them more acceptable to external or internal insults using our published protocol [17]. To assess the spe- that promote carcinogenesis. Third, as cytoplasmic cificity of immunostaining, three technical approaches p63 expression is associated with poorer patient sur- were used. First, different controls, including (1) the vival in lung cancer and tumor grade in meningiomas substitution of the primary antibody with normal [14,15], aberrant p63 expression may have oncogenic serum, (2) the omission of the secondary antibody properties that contribute to tumor aggressiveness from the immunostaining sequences, and (3) serial and invasiveness. dilutions of the primary antibodies, were used. Thus, our current study attempted to further Second, the same immunostaining protocol was used elucidate the cellular and molecular profiles of these on the same cases, but substituting with a different normal or hyperplastic appearing epithelia with cy- detection system and chromogen. Third, the immu- toplasmic p63 expression, to assess: (1) whether they nostaining procedure was repeated at least twice us- harbor aberrant expression of other tumor suppres- ing the same protocol and under the same condition sors or malignancy-associated changes, and (2) and immunostained sections were independently whether they differ substantially in DNA copy num- evaluated by two investigators. A given cell was con- bers compared to morphologically similar counter- sidered immunoreactive when distinct immunoreac- parts without cytoplasmic p63 expression. tivities were seen consistently in its membrane, cy- toplasm, or nucleus, while all negative controls were Materials and Methods devoid of immunostaining. Formalin-fixed, paraffin-embedded tissue blocks To assess whether they differ substantially in from 20 cases of PABC used in our previous studies DNA copy numbers compared to their morphologi- [11] were used for our current study. All cases were cally similar counterparts without cytoplasmic p63 diagnosed during the pregnancy or within 3-months expression, normal or hyperplastic lobules with uni- of postpoterm. No clinical following-up data, how- form cytoplasmic p63 expression in acinar cells from 4 ever, were available for these patients. For compari- PABC cases and morphologically comparable lobules son, 20 cases of stage, grade, and age matched (the same histological type, grade, and similar archi- non-PABC were selected from the files of our institute tecture and size) without cytoplasmic p63 expression and our own tissue bank. Consecutive sections at 4-5 from 4 non-PABC cases were microdissected with a μm thickness were prepared and placed on positively 30G1/2 needle, as previously described [18]. Micro- charged slides. From each tissue block, the first and dissected cells were subjected to DNA extraction and last sections were stained with hematoxylin and eosin array-comparative genomic hybridization (ar- (H&E) for morphological classification using our ray-CGH). published criteria [16]. Array-CGH was carried out using previously To assess whether these normal or hyperplastic published protocols [19,20] with minor modifications. acini harbored aberrant expression of other tumor Briefly, genomic DNAs were extracted and purified suppressors and malignancy associated alterations, using a QIAamp Kit (Cat. No. 56404, QIAGEN, Va- two technical approaches were used. First, sets of six lencia, CA, USA) following the manufacturer’s in- consecutive sections were immuno-stained for known structions. The purity of each DNA sample was indi- http://www.biolsci.org Int. J. Biol. Sci. 2010, 6 430 cated by 1.8 of the A260/A280 ratio. Two micrograms on their functions. The p-values for genes with func- of purified genomic DNA were labeled with fluores- tional annotation report were calculated using a cent Cy3-dUTP using a DNA Labeling Kit (Cat. No. modified Fisher’s Exact Test (DAVID Bioinformatics 42671, Enzo Life Sciences, Farmingdale, NY, USA) Resources 2009; http://david.abcc.ncifcrf.gov/). Sta- following the manufacturer’s instructions. Hybridiza- tistical significance was set at a p-value <0.05 and FDR tion was carried out using a Human OneArray DNA ≤ 5%. microarray

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    15 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us